Prognostic Significance of Alternative Splicing Genes in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma

References

• Benard VB, Thomas CC, King J, Massetti GM, Doria-Rose VP, Saraiya M. Vital signs: cervical cancer incidence, mortality, and screening - United States, 2007–2012. MMWR Morb Mortal Wkly Rep. 2014;63(44):1004–1009.
   PubMed Web of Science ®Google Scholar
• Gustafsson L, Ponten J, Zack M, Adami HO, Adami H-O. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control. 1997;8(5):755–763. doi:10.1023/A:1018435522475
   PubMed Web of Science ®Google Scholar
• Scarinci IC, Garcia FA, Kobetz E, et al. Cervical cancer prevention: new tools and old barriers. Cancer. 2010;116(11):2531–2542.
   PubMed Web of Science ®Google Scholar
• Soutter WP, de Barros Lopes A, Fletcher A, et al. Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet (London, England). 1997;349(9057):978–980. doi:10.1016/S0140-6736(96)08295-5
   PubMed Web of Science ®Google Scholar
• Tang JY, Lee JC, Hou MF, et al. Alternative splicing for diseases, cancers, drugs, and databases. TheScientificWorldJournal. 2013;2013:703568. doi:10.1155/2013/703568
   PubMed Web of Science ®Google Scholar
• Bowler E, Porazinski S, Uzor S, et al. Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells. BMC Cancer. 2018;18(1):355. doi:10.1186/s12885-018-4227-7
   PubMed Web of Science ®Google Scholar
• Liang Y, Song J, He D, et al. Systematic analysis of survival-associated alternative splicing signatures uncovers prognostic predictors for head and neck cancer. J Cell Physiol. 2019;234:15836–15846. doi:10.1002/jcp.28241
   PubMed Web of Science ®Google Scholar
• Xu J, Qiu Y. Role of androgen receptor splice variants in prostate cancer metastasis. Asian J Urol. 2016;3(4):177–184. doi:10.1016/j.ajur.2016.08.003
   PubMedGoogle Scholar
• Song J, Liu YD, Su J, Yuan D, Sun F, Zhu J. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma. J Cell Physiol. 2019;234:22753–22764. doi:10.1002/jcp.28840
   PubMed Web of Science ®Google Scholar
• Lin P, He RQ, Huang ZG, et al. Role of global aberrant alternative splicing events in papillary thyroid cancer prognosis. Aging. 2019;11(7):2082–2097. doi:10.18632/aging.101902
   PubMedGoogle Scholar
• Mao S, Li Y, Lu Z, et al. Survival-associated alternative splicing signatures in esophageal carcinoma. Carcinogenesis. 2019;40(1):121–130. doi:10.1093/carcin/bgy123
   PubMed Web of Science ®Google Scholar
• Zhu J, Chen Z, Yong L. Systematic profiling of alternative splicing signature reveals prognostic predictor for ovarian cancer. Gynecol Oncol. 2018;148(2):368–374. doi:10.1016/j.ygyno.2017.11.028
   PubMed Web of Science ®Google Scholar
• Kornblihtt AR, Schor IE, Allo M, Dujardin G, Petrillo E, Munoz MJ. Alternative splicing: a pivotal step between eukaryotic transcription and translation. Nat Rev Mol Cell Biol. 2013;14(3):153–165. doi:10.1038/nrm3525
   PubMed Web of Science ®Google Scholar
• Anczukow O, Krainer AR. Splicing-factor alterations in cancers. RNA (New York, NY). 2016;22(9):1285–1301. doi:10.1261/rna.057919.116
   PubMed Web of Science ®Google Scholar
• Paschalis A, Sharp A, Welti JC, et al. Alternative splicing in prostate cancer. Nat Rev Clin Oncol. 2018;15(11):663–675. doi:10.1038/s41571-018-0085-0
   PubMed Web of Science ®Google Scholar
• Shen B, Yuan Y, Zhang Y, et al. Long non-coding RNA FBXL19-AS1 plays oncogenic role in colorectal cancer by sponging miR-203. Biochem Biophys Res Commun. 2017;488(1):67–73. doi:10.1016/j.bbrc.2017.05.008
   PubMed Web of Science ®Google Scholar
• Kuleshov MV, Jones MR, Rouillard AD, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44(W1):W90–97. doi:10.1093/nar/gkw377
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Franceschini A, Wyder S, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(Database issue):D447–452. doi:10.1093/nar/gku1003
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504. doi:10.1101/gr.1239303
   PubMed Web of Science ®Google Scholar
• Tibshirani R. The lasso method for variable selection in the Cox model. Stat Med. 1997;16(4):385–395. doi:10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3
   PubMed Web of Science ®Google Scholar
• Piva F, Giulietti M, Burini AB, Principato G. SpliceAid 2: a database of human splicing factors expression data and RNA target motifs. Hum Mutat. 2012;33(1):81–85. doi:10.1002/humu.21609
   PubMed Web of Science ®Google Scholar
• Climente-Gonzalez H, Porta-Pardo E, Godzik A, Eyras E. The functional impact of alternative splicing in cancer. Cell Rep. 2017;20(9):2215–2226. doi:10.1016/j.celrep.2017.08.012
   PubMed Web of Science ®Google Scholar
• Li Y, Sun N, Lu Z, et al. Prognostic alternative mRNA splicing signature in non-small cell lung cancer. Cancer Lett. 2017;393:40–51. doi:10.1016/j.canlet.2017.02.016
   PubMed Web of Science ®Google Scholar
• Perera RM, Stoykova S, Nicolay BN, et al. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism. Nature. 2015;524(7565):361–365. doi:10.1038/nature14587
   PubMed Web of Science ®Google Scholar
• Li G, Li L, Joo EJ, et al. Glycosaminoglycans and glycolipids as potential biomarkers in lung cancer. Glycoconj J. 2017;34(5):661–669. doi:10.1007/s10719-017-9790-7
   PubMed Web of Science ®Google Scholar
• DiDonato JA, Mercurio F, Karin M. NF-kappaB and the link between inflammation and cancer. Immunol Rev. 2012;246(1):379–400. doi:10.1111/j.1600-065X.2012.01099.x
   PubMed Web of Science ®Google Scholar
• Tang D, Tao D, Fang Y, Deng C, Xu Q, Zhou J. TNF-alpha promotes invasion and metastasis via NF-kappa B pathway in oral squamous cell carcinoma. Med Sci Monit Basic Res. 2017;23:141–149. doi:10.12659/MSMBR.903910
   PubMed Web of Science ®Google Scholar
• Pacifico F, Mauro C, Barone C, et al. Oncogenic and anti-apoptotic activity of NF-kappa B in human thyroid carcinomas. J Biol Chem. 2004;279(52):54610–54619. doi:10.1074/jbc.M403492200
   PubMed Web of Science ®Google Scholar
• Guo G, Gui Y, Gao S, et al. Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma. Nat Genet. 2011;44(1):17–19. doi:10.1038/ng.1014
   PubMed Web of Science ®Google Scholar
• Zhou Q, Hou Z, Zuo S, et al. LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52. Cancer Sci. 2019;110(4):1194–1207. doi:10.1111/cas.13951
   PubMed Web of Science ®Google Scholar
• Han W, Yu G, Meng X, et al. Potential of C1QTNF1-AS1 regulation in human hepatocellular carcinoma. Mol Cell Biochem. 2019;460:37–51. doi:10.1007/s11010-019-03569-w
   PubMed Web of Science ®Google Scholar
• Leon J, Casado J, Jimenez Ruiz SM, et al. Melatonin reduces endothelin-1 expression and secretion in colon cancer cells through the inactivation of FoxO-1 and NF-kappabeta. J Pineal Res. 2014;56(4):415–426. doi:10.1111/jpi.12131
   PubMed Web of Science ®Google Scholar
• Cheng X, Wei L, Huang X, et al. Solute carrier family 39 member 6 gene promotes aggressiveness of esophageal carcinoma cells by increasing intracellular levels of zinc, activating phosphatidylinositol 3-kinase signaling, and up-regulating genes that regulate metastasis. Gastroenterology. 2017;152(8):1985–1997.e1912. doi:10.1053/j.gastro.2017.02.006
   PubMed Web of Science ®Google Scholar
• Lian J, Jing Y, Dong Q, et al. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma. Oncotarget. 2016;7(3):2672–2683. doi:10.18632/oncotarget.6603
   PubMedGoogle Scholar
• Yun M, Bang SH, Kim JW, Park JY, Kim KS, Lee JD. The importance of acetyl coenzyme A synthetase for 11C-acetate uptake and cell survival in hepatocellular carcinoma. J Nucl Med. 2009;50(8):1222–1228. doi:10.2967/jnumed.109.062703
   PubMed Web of Science ®Google Scholar
• Tada Y, Yokomizo A, Shiota M, et al. Ectonucleoside triphosphate diphosphohydrolase 6 expression in testis and testicular cancer and its implication in cisplatin resistance. Oncol Rep. 2011;26(1):161–167.
   PubMed Web of Science ®Google Scholar
• Rosin G, Hannelius U, Lindstrom L, et al. The dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancer. BMC Cancer. 2012;12:79. doi:10.1186/1471-2407-12-79
   PubMed Web of Science ®Google Scholar
• Ramalingam S, Ramamoorthy P, Subramaniam D, Anant S. Reduced expression of RNA binding protein CELF2, a putative tumor suppressor gene in colon cancer. Immuno-Gastroenterology. 2012;1(1):27–33.
   PubMedGoogle Scholar
• Yeung YT, Fan S, Lu B, et al. CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction. Carcinogenesis. 2019;41:377–389.
   Web of Science ®Google Scholar
• Fan B, Jiao BH, Fan FS, et al. Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2. Int J Oncol. 2015;47(3):1025–1033. doi:10.3892/ijo.2015.3080
   PubMed Web of Science ®Google Scholar
• Hao XL, Han F, Zhang N, et al. TC2N, a novel oncogene, accelerates tumor progression by suppressing p53 signaling pathway in lung cancer. Cell Death Differ. 2019;26(7):1235–1250. doi:10.1038/s41418-018-0202-8
   PubMed Web of Science ®Google Scholar
• Dou N, Yang D, Yu S, Wu B, Gao Y, Li Y. SNRPA enhances tumour cell growth in gastric cancer through modulating NGF expression. Cell Prolif. 2018;51(5):e12484. doi:10.1111/cpr.12484
   PubMed Web of Science ®Google Scholar
• Kurumi H, Kanda T, Kawaguchi K, et al. Protoporphyrinogen oxidase is involved in the fluorescence intensity of 5-aminolevulinic acid-mediated laser-based photodynamic endoscopic diagnosis for early gastric cancer. Photodiagnosis Photodyn Ther. 2018;22:79–85. doi:10.1016/j.pdpdt.2018.02.005
   PubMed Web of Science ®Google Scholar
• Qu JJ, Qu XY, Zhou DZ. miR4262 inhibits colon cancer cell proliferation via targeting of GALNT4. Mol Med Rep. 2017;16(4):3731–3736. doi:10.3892/mmr.2017.7057
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu W, Xu L, et al. GALNT4 predicts clinical outcome in patients with clear cell renal cell carcinoma. J Urol. 2014;192(5):1534–1541. doi:10.1016/j.juro.2014.04.084
   PubMed Web of Science ®Google Scholar
• Robert G, Jacquel A, Auberger P. Chaperone-mediated autophagy and its emerging role in hematological malignancies. Cells. 2019;8(10):1260. doi:10.3390/cells8101260
   PubMed Web of Science ®Google Scholar
• Li H, Han G, Li X, et al. MAPK-RAP1A signaling enriched in hepatocellular carcinoma is associated with favorable tumor-infiltrating immune cells and clinical prognosis. Front Oncol. 2021;11:649980. doi:10.3389/fonc.2021.649980
   PubMed Web of Science ®Google Scholar
• Liu Z, Zheng W, Liu Y, Zhou B, Zhang Y, Wang F. Targeting HSPA8 inhibits proliferation via downregulating BCR-ABL and enhances chemosensitivity in imatinib-resistant chronic myeloid leukemia cells. Exp Cell Res. 2021;405(2):112708. doi:10.1016/j.yexcr.2021.112708
   PubMed Web of Science ®Google Scholar
• Wang L, Bi J, Li X, Wei M, He M, Zhao L. Prognostic alternative splicing signature reveals the landscape of immune infiltration in pancreatic cancer. J Cancer. 2020;11(22):6530–6544. doi:10.7150/jca.47877
   PubMed Web of Science ®Google Scholar
• Yang Y. Cancer immunotherapy: harnessing the immune system to battle cancer. J Clin Invest. 2015;125(9):3335–3337. doi:10.1172/JCI83871
   PubMed Web of Science ®Google Scholar
• Wculek SK, Cueto FJ, Mujal AM, Melero I, Krummel MF, Sancho D. Dendritic cells in cancer immunology and immunotherapy. Nat Rev Immunol. 2020;20(1):7–24. doi:10.1038/s41577-019-0210-z
   PubMed Web of Science ®Google Scholar
• Walch-Rückheim B, Ströder R, Theobald L, et al. Cervical cancer-instructed stromal fibroblasts enhance IL23 expression in dendritic cells to support expansion of Th17 cells. Cancer Res. 2019;79(7):1573–1586. doi:10.1158/0008-5472.CAN-18-1913
   PubMed Web of Science ®Google Scholar
• Chen S, Lv M, Fang S, Ye W, Gao Y, Xu Y. Poly(I:C) enhanced anti-cervical cancer immunities induced by dendritic cells-derived exosomes. Int J Biol Macromol. 2018;113:1182–1187. doi:10.1016/j.ijbiomac.2018.02.034
   PubMed Web of Science ®Google Scholar
• Liu J, Yang J, Gao F, et al. A microRNA-messenger RNA regulatory network and its prognostic value in cervical cancer. DNA Cell Biol. 2020;39(7):1328–1346. doi:10.1089/dna.2020.5590
   PubMed Web of Science ®Google Scholar
• van der Burg SH, Piersma SJ, de Jong A, et al. Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens. Proc Natl Acad Sci USA. 2007;104(29):12087–12092. doi:10.1073/pnas.0704672104
   PubMed Web of Science ®Google Scholar
• Garcia-Chagollan M, Jave-Suarez LF, Haramati J, et al. An approach to the immunophenotypic features of circulating CD4+NKG2D+ T cells in invasive cervical carcinoma. J Biomed Sci. 2015;22:91. doi:10.1186/s12929-015-0190-7
   PubMed Web of Science ®Google Scholar
• Pilch H, Hoehn H, Schmidt M, et al. CD8+CD45RA+CD27-CD28-T-cell subset in PBL of cervical cancer patients representing CD8+T-cells being able to recognize cervical cancer associated antigens provided by HPV 16 E7. Zentralbl Gynakol. 2002;124(8–9):406–412. doi:10.1055/s-2002-38130
   PubMedGoogle Scholar
• Komdeur FL, Prins TM, van de Wall S, et al. CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer. Oncoimmunology. 2017;6(9):e1338230. doi:10.1080/2162402X.2017.1338230
   PubMed Web of Science ®Google Scholar